Tilfrinib
Tilfrinib is a potent and selective Brk (Breast Tumor Kinase) inhibitor with an IC50 of 3.15 nM. It demonstrates anti-proliferative activity in cellular assays and has shown anti-tumor efficacy in vivo, making it a valuable tool for oncology research targeting Brk-dependent signaling pathways.
Product Specifications
CAS Number
1600515-49-8
Product Name Alternative
BRK, Brk, Tilfrinib
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.54% (May vary between batches)
Solubility
DMSO:112.5 mg/mL (408.65 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (14.53 mM)
Smiles
Oc1cccc (Nc2ccnc3[nH]c4ccccc4c23) c1
Molecular Formula
C17H13N3O
Molecular Weight
275.3
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
